Valmec Limited

Data provenance.

• FY2020 and FY2021 revenue are from the Scheme Booklet (1 Sep 2021, section 6.2.6).

• FY2018 revenue and EBITDA are from company results coverage (SmallCaps, Aug 2018).

• FY2019 figures are from company announcements as summarised by Strawman and Datt Capital.

• FY2017 revenue is derived (A$103 million ÷ 1.41).

• NPAT figures for FY18–FY20 are derived from NPAT margins in an investor analysis of the 2020 Annual Report (Strawman). These are secondary-source figures and are flagged.

• The FY2021 EBITDA of A$16.22 million comes from the Preqin aggregator, which labels it "USD" but is evidently reproducing the A$ Scheme Booklet figures, since its revenue of 137,451 matches. It is therefore treated as an unconfirmed A$ figure.

Income statement

Notes on the income statement:

• FY2018 EBITDA was reported as "exceeding A$7.5 million". FY2019 underlying growth was quoted as 11% on the FY18 underlying A$7.3 million.

• H1 FY2021 (six months to 31 Dec 2020): revenue about A$61 million, EBITDA about A$6.1 million, NPAT about A$3.0 million (Strawman, secondary). This implies H2 FY21 revenue of about A$76.5 million.

• The FY2021 outlook given with the half-year results was about A$126 million revenue, A$12.6 million EBITDA and A$6.2 million NPAT (Strawman, secondary). Actual revenue of A$137.5 million exceeded that outlook by about 9%.

• The Scheme Booklet records total FY21 dividends of 1.20 cents per share (ordinary plus special, related to the litigation settlement).

• Dividends were suspended from July 2016.

Revenue CAGR

• FY17–FY21 four-year CAGR: about 17.1% (using derived FY17 revenue).

• FY18–FY21 three-year CAGR: about 10.1%.

Commentary. The revenue trajectory has three phases.

1. FY2016–FY2018 (gas-led surge). Revenue doubled in 24 months to A$103 million, driven by east-coast gas compression and pipeline projects. These benefited from the Exterran franchise and the post-2016 recovery of the resources cycle.

2. FY2019–FY2020 (plateau). Revenue was flat at A$110–112 million. FY20 suffered COVID-related deferrals. EBITDA margin compressed from about 7.3% to about 4.6%, and NPAT collapsed to about A$0.2 million, implying heavy depreciation, AASB 16 lease charges and interest relative to EBITDA. Management itself described FY20 revenue as disappointing (investor commentary on the 2020 Annual Report).

3. FY2021 (inflection). Revenue jumped about 23% to a record A$137.5 million, with the order book above A$200 million. The reported EBITDA margin of about 11.8% (if confirmed) is materially above the 7–8% historical run-rate. That likely reflects (a) operating leverage on fixed workshop and overhead costs, (b) a higher services mix, and (c) possible one-off benefits from the litigation settlement.

Earnings quality before FY21 was weak. The gap between EBITDA (7–8% margins) and NPAT (0.2–3.2% margins) indicates a capital-intensive model with meaningful D&A, leases and finance costs. The legacy dispute also held receivables and contract assets in limbo.

Balance sheet

Notes on the balance sheet:

• NTA per share of A$0.18 at 30 June 2020 is after adoption of AASB 16, per the 2020 Annual Report (page 24) as cited by a Strawman member.

• FY2021 shares on issue are implied: equity value of about A$52 million ÷ A$0.413.

• The Exterran (2015) and APTS (2018) acquisitions were both funded by a mix of cash reserves or working capital and additional debt facilities, so the group carried bank debt. The scheme conditions included that no lender demand early repayment (change-of-control), confirming that loan facilities were in place in 2021 (MarketScreener summary of the SID).

• The amounts, maturities and covenants are not publicly disclosed in the sources verified.

Cash flow

Notes on cash flow:

• No buyback programme is recorded in the sources verified.

Ratios

Notes on ratios:

• The FY2020 trailing P/E of about 97x was quoted from CommSec by an investor at the time; the new ASX site showed 116x (Strawman). It reflects near-zero FY20 NPAT.

Qualitatively, Valmec's balance sheet was that of a working-capital-intensive contractor:

• modest tangible equity (NTA of about A$23 million at A$0.18 × about 126 million shares; derived);

• bank debt used for acquisitions;

• a material contested receivable, the roughly A$11.6 million John Holland claim, which represented about half of FY20 NTA.

The 2021 settlement of the litigation, followed by a special dividend, de-risked the balance sheet immediately before the sale.

Post-acquisition financial context (parent: Altrad group, EUR)

Valmec's numbers are now consolidated into the Altrad group. For context:

Sources: Altrad FY2024 results (year to 31 Aug 2024) via Scaffmag; Altrad FY2025 results presentation (16 Jan 2026); S&P Global Ratings tearsheet (5 Feb 2026).

• FY2025 sales were up 9%, EBITDA up 10% and free cash flow up 19.6%.

• S&P-adjusted EBITDA margin in FY2025 was 11.1%.

• 41% of Altrad's FY2025 revenue was generated in the UK.

Management guidance. There is no Valmec-level guidance since delisting. At parent level, S&P expects Altrad to remain resilient in FY2026, with adjusted EBITDA margins stable at about 11%. Altrad's own framework targets about 11% EBITDA margin and capex of 2.0–2.5% of revenue per year (S&P Feb 2026; Altrad FY25 presentation).

Consensus: not applicable (no coverage).

Bull case

1. Platform scale. Valmec now sits inside an Australian Altrad platform with about A$700 million in revenue (2024). It can bid integrated scopes (engineering, construction, access, maintenance) that the A$137 million standalone business could not.

2. Annuity franchise. Its gas-compression aftermarket franchise (OEM-authorised, Tier-1 clients) combined with APTS testing should provide steady, higher-margin recurring revenue even if new gas capex slows. About 67% of the 2021 order book was recurring.

3. Momentum into the sale. The FY21 inflection (revenue +22.7%, EBITDA margin reported at about 11.8%), combined with a A$1.1 billion pipeline, suggests the business was sold at a cyclical trough multiple of about 3–4x EBITDA. That implies strong value accretion for Altrad.

Bear case

1. Thin underlying earnings. Pre-FY21 net margins of 0.2–3.2% indicate that underlying earnings power is modest. The FY21 EBITDA may include one-off settlement benefits, which are not separable in verified data.

2. Weak end-market outlook. Decarbonisation is a structural headwind for gas infrastructure, and industry-wide hydrogen project deferrals blunt the energy-transition hedge.

3. Brand dilution and opacity. Inside a founder-controlled parent that pays large dividends (€165 million in Aug 2025), Valmec's brand, people and capital allocation are subordinate to group priorities. Volatile WA staff rankings hint at retention pressure.

Key catalysts and monitorables (next 12 months)

1. Altrad's FY2026 results (year to 31 Aug 2026; expected around Jan 2027) and any Asia-Pacific segment commentary.

2. Any rebranding of Valmec into "Altrad" in Australia, or further consolidation with AusGroup and Sparrows.

3. Business News WA contractor rankings (staff trends).

4. Contract awards in east-coast gas compression, Water Corporation programmes and WA resources.

5. Australian hydrogen project FIDs or cancellations.

6. S&P rating actions on Altrad.

7. Leadership: confirmation of Steve Dropulich's continued role.

Concluding analyst verdict

Valmec Limited no longer exists as an investable listed security. The ASX: VMX identifiers in the source list are five years out of date. The company was acquired by Altrad Australia for about A$52 million (A$0.413 per share) through a scheme implemented on 15 October 2021, and has since operated as "Valmec (Part of the Altrad Group)". Any assessment must therefore treat Valmec as an operating division whose economics are now visible only through its parent.

On its record as a listed company, Valmec was a competent but structurally low-margin mid-tier contractor. It made two well-timed, capital-light acquisitions: Exterran Australia in 2015, which created a durable gas-compression aftermarket franchise, and the distressed APTS in 2018, which added accredited testing capability. Those acquisitions roughly doubled revenue to more than A$100 million by FY18. Profitability nonetheless lagged until FY21. In that year revenue rose about 23% to A$137.5 million, the order book exceeded A$200 million and a long-running construction dispute was settled. The board sold at that inflection point. The independent expert judged the price fair and reasonable, and it exceeded every trade in the prior five years. With hindsight, it still looks inexpensive on FY21 metrics: about 0.4x sales and roughly 3–4x EBITDA, depending on which EBITDA figure is used.

For Altrad, Valmec has served a strategic rather than financial purpose. It provides an engineered-construction and specialist-services layer that moves the group up the value chain in Australia, and it complements the AusGroup, Sparrows and APTS businesses on an Australian platform with about A$700 million of revenue. The key uncertainties are Valmec's exposure to the gas sector as energy policy shifts and the slow progress of hydrogen projects. Its strengths are its recurring maintenance and testing work and the backing of a parent with €5.9 billion of revenue and moderate leverage.

Verdict: this is not actionable as a standalone equity. Valmec is best monitored as a strategically sound, well-integrated bolt-on whose value now depends on Altrad's Asia-Pacific execution and credit profile.